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Abstract 
The promoter activity of 1432 bp upstream of the human prostaglandin-endoperoxide synthase 2 gene (PrGS2) was examined in differentiated 
U937 monocytic cells expressing prostaglandin-endoperoxide synthase 2 mRNA. Transient ransfection experiments were performed using these cells 
and reporter vectors containing the upstream region of the gene with deletions or site-specific mutations and the luciferase gene. The deletion or 
destruction of the cyclic AMP response lement (nucleotides -59 to -53) markedly reduced the promoter activity of this gene. Electrophoretic mobility 
shift assays howed that a nuclear protein(s) binding to the cyclic AMP response lement was induced during monocytic differentiation of U937 cells. 
These results indicate that expression of the human prostaglandin-endoperoxide synthase 2 gene in differentiated U937 monocytic cells is regulated 
by the cyclic AMP response element. 
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1. Introduction 
Prostaglandin-endoperoxide synthase (PES) catalyzes 
the first committed step of the biosynthesis of prosta- 
glandins, prostacyclin and thromboxane which are po- 
tent biological mediators [1,2]. It is now evident that 
there exist two distinct isozymes for PES: a well-charac- 
terized constitutive isozyme, designated PES-1 or cy- 
clooxygenase- 1; and a newly discovered inducible 
isozyme, PES-2 or cyclooxygenase-2. The human [3] and 
mouse [4] PES-2 genes spanning 8.0-8.3 kb are smaller 
than the human [5,6] and mouse [7] PES-1 genes being 
22 kb in size and consisting of 10 exons. The exon struc- 
tures of the PES-2 and -1 genes are similar except for the 
first and last exons [3,5,7]. The human PES-2 gene was 
mapped to chromosome lq25.2-q25.3 whereas the PES-1 
gene was mapped to chromosome 9q32-q33.3 [3], indi- 
cating that the two genes are not linked. It is noteworthy 
that PES-2 mRNA is rapidly induced by a variety of 
factors, i.e. inflammatory mediators, growth factors, mi- 
togens and gonadotropin [8-l I]. 
The nucleotide sequence of the 5’-flanking region of 
the human PES-2 gene contains a canonical TATA box 
and various transcriptional regulatory elements [3] but 
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does not show significant similarity to the 5’-flanking 
regions of human and mouse PES-I genes which lack a 
TATA box [6,7]. The nucleotide sequences of the human 
[3], mouse [4] and rat [l l] PES-2 genes in their 5’-flanking 
regions share 60-63% similarity among the 275-bp nucle- 
otide residues upstream of the transcriptional start site. 
It is noteworthy that in all three genes the sequences 
homologous to the consensus NF-IL6 site and the cyclic 
AMP response element (CRE) are conserved. From this 
study using human differentiated U937 monocytic cells 
we report that the conserved CRE in the human PES-2 
gene plays an essential role in the efficient promoter 
activity of the gene. 
2. Materials and methods 
2. I. Ceil culture 
U937 cells were supplied by the Japanese Cancer Research Resources 
Bank and maintained in suspension in RPM1 1640 medium supple- 
mented with 10% (v/v) fetal bovine serum, penicillin (100 U/ml) and 
streptomycin (100 pg/ml) (‘complete culture medium’) at 37°C in a 
humidified atmosnhere of 5% CO, in air. For differentiation. U937 cells 
were plated at 1.2’~ IO’ cells/l 50 mm dish in the medium containing 100 
nM 12-0-tetradecanoylphorbol-I 3 acetate (TPA; Sigma) and allowed 
to adhere for 48 h. 
2.2. RNA blot analysis 
RNA blot analysis was performed as described previously [3]. Total 
RNA was isolated according to the acid guanidinium thiocyanate pro- 
cedure [I21 and 20 &lane of the total RNA was used for the electro- 
phoresis. The probe used was the entire I S-kb insert of the recombinant 
plasmid pHPESIIl7 encoding the human PES-2 cDNA [3]. 
2.3. Plasmids 
pGV-B, the promoterless luciferase reporter vector, and pGV-C, the 
luciferase reporter vector under the control of the SV40 promoter/ 
enhancer were purchased from Toyo Inc., Tokyo. pCMV#gal, the 
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p-galactosidase reporter vector under the control of the human cy- 
tomegalovirus promoter, was obtained from Karl Normington (Uni- 
versity of Texas Southwestern Medical Center at Dallas). These expres- 
sion vectors were used as controls in the transfection experiments. The 
HaeII-digested fragment, corresponding to nucleotide positions -327 
to +59 from the transcription start site of the human PES-2 gene, was 
isolated from the recombinant phage containing the human PES-2 
genomic sequence (AhPESII95) [3], blunt-ended and then subcloned 
into the SmaI site of pBluescript II SK(+) (Stratagene). Then, the 
inserted fragment digested with BumHI and Hind111 from the sub- 
cloned plasmid DNA was ligated into the Bg/II and Hind111 sites of 
pGV-B DNA and this construct was designated phPES2(-327/+59) 
(Fig. 2A). The construct phPES2(-1432/+59) was prepared using 
phPES2(-327/+59) and the KpnI-Hind111 restriction fragment of the 
human genomic PES-2 clone. Fragments coding for the nucleotide 
residues -52/+59, -124/+59 and -220/+59 were generated by the 
polymerase chain reaction (PCR) using respective primer sets Pk (5’- 
TTgagCtCATGGGCTTGGTTTTCAGT-3’)/P7 (5’-CCTCTAGAG- 
GATAGAATGGG-3’, originated from the sequence of the pGV-B 
vector), P4 (5’-TTggtacc-TTTTTTTAAGGGGAGAGGA-3’)/P7 and 
P2 (5’-AGAGTGcac-ACTACCCCCTCTGCTCCCAA-3’VP7 and 
phPES2(-327/+59) as a template (Fig. 2A). Lower case letters in the 
nucleotide sequences described above represent the nucleotide residues 
which have been changed to introduce new restriction enzyme sites. The 
mutant constructs were prepared by insertion of PCR-amplified nucle- 
otides into pGV-B. Namely, the amplified DNA fragment using the 
primer set P6lP7 or P4/P7 was digested by HindIIIISucI or HindIIIl 
KpnI and inserted into the HindIIIlSacI or HindIIIlKpnI sites of pGV- 
B, respectively (Fig. 2A). In addition, the amplified DNA fragment 
using the primer set P2/P7 was digested by Alw441, blunt-ended by T4 
DNA polymerase, digested by HindIII, and then inserted into the 
HindIIIlSman sites of pGV-B (Fig. 2A). These deletion constructs thus 
prepared were designated phPES2(-52/+59), phPES2(-124/+59) and 
phPES2(-220/+59). Mutant constructs. DhPES2(CRM) with a muta- 
iion at 6RE and phPES2(ILM) with a’mutation-at NF-IL6 site were 
prepared by ligation of each PCR product using primer set Pl (S- 
TTGTCC AAACTCATCAATG-3’, originating from the sequence of 
pGV-B)/P5 (S-atGaGctc AAATGACTGTTTCTTTCCG-3’) or PI/P3 
(5’-AAggtaccAAGCCCGGTGGGGG CAGGG-3’) and phPES2(-521 
+59) or phPES2(-124/+59) as shown in Fig. 2A. The oligonucleotide 
primers were synthesized on an Applied Biosystems 391 DNA synthe- 
sizer. Each construct was verified by DNA sequence analysis as de- 
scribed in [3]. 
2.4. DNA transfections 
A total of 1.4 x 10’ U937 cells differentiated by TPA were transfected 
with 30 pg of each reporter plasmid, 10 fig of pCMV-pgal and 100 pg 
of sonicated salmon sperm DNA by electroporation at 300 V and 960 
PF in 700 ~1 of Dulbecco’s phosphate-buffered saline, using a Bio-Rad 
Gene Pulser. Expression of j3-galactosidase derived from pCMV$?gal 
was used as an internal control of the transfections. Cells were resus- 
pended in the complete culture medium and cultivated for 20 h. Cells 
were harvested, and luciferase andj%galactosidase activities were deter- 
mined by aluminometer (Berthold) [13] and a method using chlorophe- 
no1 red b-D-galactopyranoside as substrate [14], respectively. Experi- 
ments were repeated at least three times. The promoter activity in 
undifferentiated U937 cells could not be evaluated because of the very 
low transfection efficiency. 
2.5. Nuclear extracts and elecfrophoretic mobility shift assay 
Nuclear extracts were prepared as described by Andrews and Faller 
[15]. The following oligonucleotides were made by a DNA synthesizer: 
S-AAACAGTCA TTTCGTCACATGGGCTTG-3’, containing the 
consensus CRE sequence of the human PES-2 gene (indicated by under- 
line; PES-2CRE); 5’-AAACAGTCA TTTgagCtCATGGGCTTG-3’, 
containing a four-point mutation (indicated by lower case letters) 
within the consensus CRE sequence by introducing the Sac1 site (PES- 
ZCRM). Complementary oligonucleotides synthesized separately were 
annealed in 20 mM Tris-HCl (pH 7.6), 50 mM NaCl, 10 mM MgCl, 
and 1 mM dithiothreitol. The annealed oligonucleotide PES-2CRE was 
phosphorylated at the 5’-end with [y-‘*P]ATP (110 TBq/mmol, Amer- 
sham) and T4 polynucleotide kinase. Electrophoretic mobility shift 
assays using synthesized oligonucleotides were carried out as described 
t131. 
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Fig. 1. Expression of the human PES-2 gene. RNA blot analysis of total 
RNAs (20 @lane) from undifferentiated U937 cells (lane 1) and from 
the monocytic differentiated U937 cells treated with TPA for 48 h and 
cultured overnight in TPA-free medium (lane 2). The RNA markers are 
18 S and 28 S ribosomal RNAs. 
3. Results and discussion 
3.1. Expression of PES-2 mRNA in differentiated U937 
human monocytic cells 
Human monoblastoid U937 cells differentiate into 
macrophage-like cells following incubation with TPA for 
48 h [16]. TPA-induced ifferentiation results in the ces- 
sation of proliferation of cells and alteration in their 
morphology from non-adherent o adherent cells. Previ- 
ously the rapid and transient induction of PES-2 mRNA 
by TPA was reported with HEL cells [ 171, Swiss 3T3 cells 
[8] and human umbilical vein endothelial cells [9]; the 
mRNA levels increased maximally within 2-6 h after the 
stimulation and decreased rapidly. The human mono- 
blastoid U937 cells, however, did not show such a rapid 
and transient increase of PES-2 mRNA by TPA treat- 
ment, and a gradual and stable increase in mRNA was 
observed after the treatment of the cells for 24 h (data 
not shown). Therefore, we treated the cells with TPA for 
48 h and cultured them overnight in TPA-free medium. 
RNA blot analysis showed that these cells expressed e- 
tectable levels of PES-2 mRNA with an expected size of 
about 4 kb [9] as shown in Fig. 1. The PES-2 mRNA was 
undetectable in undifferentiated U937 cells. Thus, the 
transfection experiments were carried out using U937 
cells treated with TPA for 48 h, and after transfection the 
cells were maintained in TPA-free medium for 20 h prior 
to harvest. 
3.2. Functional activity of the human PES-2 promoter in 
differentiated U937 monocytic cells 
To determine if the 5’-flanking region of the human 
PES-2 gene contains functional domains for its pro- 
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moter, transient DNA transfection experiments using lu- 
ciferase as a reporter gene in differentiated U937 cells 
were performed using deletion and site-specific mutants 
of the human PES-2 promoter (Fig. 2). As shown in Fig. 
2B, the luciferase activity observed with the reporter vec- 
tor phPES2(-1432/+59) or phPES2(-327/+59) in the 
transfected cells was about lo-times higher than that 
with pGV-C. The luciferase activity derived from the 
pGV-C expression vector with the SV40 promoter/en- 
hancer was about 5-times higher than that derived from 
a promoterless expression vector pGV-B (data not 
shown). These results show that the functional promoter 
region is located within the 5’-flanking sequence -3271 
+59 from the transcription start site which contains the 
consensus equences for NF-lcB, NF-IL6 and CRE. 
Therefore, the consensus equences for NF-KB (-2331 
-214) NF-IL6 (-132/-124) and CRE (-59/-53) in the 
proximal 5’-flanking region of the human PES-2 gene [3] 
were deleted singly or in combinations in order to ana- 
lyze their roles in controlling the expression of the human 
PES-2 gene (Fig. 2A). The luciferase activity using a 
deletion mutant reporter vector phPES2(-52/+59) with 
no consensus sequence for NF-KB, NF-IL6 and CRE 
was only about 5% of that using a wild-type vector 
phPES2(-327/+59), whereas luciferase activities using 
phPES2(-124/+59) with only the CRE sequence and 
phPES2(-220/+59) with both NF-IL6 site and CRE se- 
quences were about 77% and 70% of that using 
phPES2(-327/+59), respectively. 
These results suggested that the CRE is essential for 
efficient transcription of the human PES-2 gene in TPA- 
differentiated U937 cells. To confirm this possibility, a 
reporter vector phPES2(CRM) with a mutation at CRE 
was transfected into TPA-differentiated U937 cells. The 
luciferase activity derived from this construct was only 
about 20% of that using phPES2(-327/+59), whereas the 
luciferase activity using a reporter vector phPES2(ILM) 
with a mutation at the NF-IL6 site was about 85% of 
that using phPES2(-327/+59). These results clearly indi- 
cate that the CRE appears to be more important than the 
NF-IL6 site for expression of the human PES-2 gene in 
differentiated U937 human monocytic cells. 
3.3. Induction of a protein binding to CRE during 
monocytic differentiation of U937 cell 
To analyze the expression of nuclear binding pro- 
tein(s) specific for CRE during monocytic differentiation 
of U937 cells, electrophoretic mobility shift assays were 
performed using the oligonucleotide for the CRE of the 
human PES-2 gene (PES-2CRE), or its mutant (PES- 
2CRM). As shown in Fig. 3, a band indicated by an 
arrow was observed in the differentiated U937 cells (lane 
2) but not in the undifferentiated U937 cells (lane 1) 
when PES-2CRE was used as a labeled probe. Moreover, 
this band was chased by the unlabeled PES-2CRE as a 
competitor (lanes 3-5) but not by the unlabeled mutant 
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Fig. 2. (A) Schematic representation of the 5’-flanking region of the 
human PES-2 gene used in the transfection experiments. The S-flank- 
ing region (thick line) and multi-cloning sites derived from pBluescript 
II (thin line) in the luciferase reporter vector phPES2(-327/+59) (see 
section 2) are shown. The NF-KB site (open box), NF-IL6 site (shaded 
box) and CRE (closed box) are indicated with their sequences, together 
with the sequences introduced with the restriction enzymes Alw441, 
Sac1 and KpnI (lower case letters and ‘x’ represent the changed nucleo- 
tide and its positions, respectively). PCR products are indicated as lines 
with the restriction enzyme sites and the relative positions of their 
primers (PI-P7) shown as arrows. (B) Promoter activity of the S- 
flanking region of the human PES-2 gene. Constructs were transiently 
transfected into the differentiated U937 cells, together with pCMV#gal 
used as an internal control of the transfections. Results are represented 
as relative luciferase activities obtained by dividing the normalized 
luciferase activity from the reporter vector pGV-C under the control 
of the SV40 promoter/enhancer. Experiments were carried out in 
triplicate. The data are presented as means f S.D. 
oligonucleotide PES-2CRM (lanes 6-8). These results 
show that a nuclear binding protein(s) specific for the 
CRE consensus sequence of the human PES-2 gene is 
induced during monocytic differentiation of U937 cells. 
These results are consistent with our previous observa- 
tion that PES-2 mRNA is rapidly induced by forskolin 
in differentiated U937 cells but not in undifferentiated 
cells [3]. Taken together, these results show that CRE 
plays an essential role in the expression of the human 
PES-2 gene in U937 cells. 
The results of this study clearly demonstrate that the 
expression of the human PES-2 gene appears to be regu- 
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Fig. 3. Electrophoretic mobility shift assays using the labeled oligonu- 
cleotide containing the consensus CRE sequence from the human PES- 
2 gene (PES-2CRE). The nuclear extract (5 pg) from undifferentiated 
(lane 1) or TPA-differentiated (lanes 2-8) U937 cells was incubated with 
the “P-labeled PES2CRE. ‘Cold-chase’ experiments were performed 
using a l&fold (lanes 3 and 6), 30-fold (lanes 4 and 7) and 50-fold (lanes 
5 and 8) molar excess of competitor oligonucleotide PES-2CRE (lanes 
3-5) or its mutant PES-2CRM (lanes 68). The sequences of these 
oligonucleotides are shown in section 2. 
lated by CRE in differentiated U937 human monocytic 
cells. Recently, Herschman et al. also showed that CRE 
is responsible for expression of the murine PES-2 gene 
(H.R. Herschman, personal communication). On the 
other hand, the NF-IL6 (CIEBP/?) site has been sug- 
gested to play a key role in regulating the induction of 
the rat PES-2 gene in granulosa cells prior to ovulation 
[18]. In this context, we note that the luciferase activity 
of phPES2(CRM), which contains NF-IL6 and NF-KB 
sites but lacks CRE, was higher than that of 
phPES2(-52/+59) lacking all these sites (Fig. 2). Interest- 
ingly, there is evidence showing that NF-IL6 and NF-KB 
are involved in the expression of genes by inflammatory 
stimulants such as lipopolysaccharide and interleukin 1 
[19]. Further, the induction of PES-2 mRNA has been 
reported with lipopolysaccharide in macrophages and 
monocytes [20]. These facts suggest that the NF-IL6 and/ 
or NF-KB sites in the human PES-2 gene may contribute 
to the expression of the human PES-2 gene. In addition 
H. hue et al. IFEBS Letters 350 (1994) 51-54 
to CRE, NF-IL6 and NF-KB sites, the S-flanking region 
of the human PES-2 gene contains many other transcrip- 
tional regulatory elements [3] and the PES-2 mRNA can 
be induced by a variety of factors. Thus further studies 
are necessary for an understanding of the transcriptional 
regulation of the PES-2 gene. 
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